Cargando…

Small Dense Low‐Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study

BACKGROUND: Elevated plasma levels of direct low‐density lipoprotein cholesterol (LDL‐C), small dense LDL‐C (sdLDL‐C), low‐density lipoprotein (LDL) triglycerides, triglycerides, triglyceride‐rich lipoprotein cholesterol, remnant lipoprotein particle cholesterol, and lipoprotein(a) have all been ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikezaki, Hiroaki, Lim, Elise, Cupples, L. Adrienne, Liu, Ching‐Ti, Asztalos, Bela F., Schaefer, Ernst J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174280/
https://www.ncbi.nlm.nih.gov/pubmed/33586462
http://dx.doi.org/10.1161/JAHA.120.019140
_version_ 1783702874615709696
author Ikezaki, Hiroaki
Lim, Elise
Cupples, L. Adrienne
Liu, Ching‐Ti
Asztalos, Bela F.
Schaefer, Ernst J.
author_facet Ikezaki, Hiroaki
Lim, Elise
Cupples, L. Adrienne
Liu, Ching‐Ti
Asztalos, Bela F.
Schaefer, Ernst J.
author_sort Ikezaki, Hiroaki
collection PubMed
description BACKGROUND: Elevated plasma levels of direct low‐density lipoprotein cholesterol (LDL‐C), small dense LDL‐C (sdLDL‐C), low‐density lipoprotein (LDL) triglycerides, triglycerides, triglyceride‐rich lipoprotein cholesterol, remnant lipoprotein particle cholesterol, and lipoprotein(a) have all been associated with incident atherosclerotic cardiovascular disease (ASCVD). Our goal was to assess which parameters were most strongly associated with ASCVD risk. METHODS AND RESULTS: Plasma total cholesterol, triglycerides, high‐density lipoprotein cholesterol, direct LDL‐C, sdLDL‐C, LDL triglycerides, remnant lipoprotein particle cholesterol, triglyceride‐rich lipoprotein cholesterol, and lipoprotein(a) were measured using standardized automated analysis (coefficients of variation, <5.0%) in samples from 3094 fasting subjects free of ASCVD. Of these subjects, 20.2% developed ASCVD over 16 years. On univariate analysis, all ASCVD risk factors were significantly associated with incident ASCVD, as well as the following specialized lipoprotein parameters: sdLDL‐C, LDL triglycerides, triglycerides, triglyceride‐rich lipoprotein cholesterol, remnant lipoprotein particle cholesterol, and direct LDL‐C. Only sdLDL‐C, direct LDL‐C, and lipoprotein(a) were significant on multivariate analysis and net reclassification after adjustment for standard risk factors (age, sex, hypertension, diabetes mellitus, smoking, total cholesterol, and high‐density lipoprotein cholesterol). Using the pooled cohort equation, many specialized lipoprotein parameters individually added significant information, but no parameter added significant information once sdLDL‐C (hazard ratio, 1.42; P<0.0001) was in the model. These results for sdLDL‐C were confirmed by adjusted discordance analysis versus calculated non–high‐density lipoprotein cholesterol, in contrast to LDL triglycerides. CONCLUSIONS: sdLDL‐C, direct LDL‐C, and lipoprotein(a) all contributed significantly to ASCVD risk on multivariate analysis, but no parameter added significant risk information to the pooled cohort equation once sdLDL‐C was in the model. Our data indicate that small dense LDL is the most atherogenic lipoprotein parameter.
format Online
Article
Text
id pubmed-8174280
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-81742802021-06-11 Small Dense Low‐Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study Ikezaki, Hiroaki Lim, Elise Cupples, L. Adrienne Liu, Ching‐Ti Asztalos, Bela F. Schaefer, Ernst J. J Am Heart Assoc Original Research BACKGROUND: Elevated plasma levels of direct low‐density lipoprotein cholesterol (LDL‐C), small dense LDL‐C (sdLDL‐C), low‐density lipoprotein (LDL) triglycerides, triglycerides, triglyceride‐rich lipoprotein cholesterol, remnant lipoprotein particle cholesterol, and lipoprotein(a) have all been associated with incident atherosclerotic cardiovascular disease (ASCVD). Our goal was to assess which parameters were most strongly associated with ASCVD risk. METHODS AND RESULTS: Plasma total cholesterol, triglycerides, high‐density lipoprotein cholesterol, direct LDL‐C, sdLDL‐C, LDL triglycerides, remnant lipoprotein particle cholesterol, triglyceride‐rich lipoprotein cholesterol, and lipoprotein(a) were measured using standardized automated analysis (coefficients of variation, <5.0%) in samples from 3094 fasting subjects free of ASCVD. Of these subjects, 20.2% developed ASCVD over 16 years. On univariate analysis, all ASCVD risk factors were significantly associated with incident ASCVD, as well as the following specialized lipoprotein parameters: sdLDL‐C, LDL triglycerides, triglycerides, triglyceride‐rich lipoprotein cholesterol, remnant lipoprotein particle cholesterol, and direct LDL‐C. Only sdLDL‐C, direct LDL‐C, and lipoprotein(a) were significant on multivariate analysis and net reclassification after adjustment for standard risk factors (age, sex, hypertension, diabetes mellitus, smoking, total cholesterol, and high‐density lipoprotein cholesterol). Using the pooled cohort equation, many specialized lipoprotein parameters individually added significant information, but no parameter added significant information once sdLDL‐C (hazard ratio, 1.42; P<0.0001) was in the model. These results for sdLDL‐C were confirmed by adjusted discordance analysis versus calculated non–high‐density lipoprotein cholesterol, in contrast to LDL triglycerides. CONCLUSIONS: sdLDL‐C, direct LDL‐C, and lipoprotein(a) all contributed significantly to ASCVD risk on multivariate analysis, but no parameter added significant risk information to the pooled cohort equation once sdLDL‐C was in the model. Our data indicate that small dense LDL is the most atherogenic lipoprotein parameter. John Wiley and Sons Inc. 2021-02-15 /pmc/articles/PMC8174280/ /pubmed/33586462 http://dx.doi.org/10.1161/JAHA.120.019140 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Ikezaki, Hiroaki
Lim, Elise
Cupples, L. Adrienne
Liu, Ching‐Ti
Asztalos, Bela F.
Schaefer, Ernst J.
Small Dense Low‐Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study
title Small Dense Low‐Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study
title_full Small Dense Low‐Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study
title_fullStr Small Dense Low‐Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study
title_full_unstemmed Small Dense Low‐Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study
title_short Small Dense Low‐Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study
title_sort small dense low‐density lipoprotein cholesterol is the most atherogenic lipoprotein parameter in the prospective framingham offspring study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174280/
https://www.ncbi.nlm.nih.gov/pubmed/33586462
http://dx.doi.org/10.1161/JAHA.120.019140
work_keys_str_mv AT ikezakihiroaki smalldenselowdensitylipoproteincholesterolisthemostatherogeniclipoproteinparameterintheprospectiveframinghamoffspringstudy
AT limelise smalldenselowdensitylipoproteincholesterolisthemostatherogeniclipoproteinparameterintheprospectiveframinghamoffspringstudy
AT cupplesladrienne smalldenselowdensitylipoproteincholesterolisthemostatherogeniclipoproteinparameterintheprospectiveframinghamoffspringstudy
AT liuchingti smalldenselowdensitylipoproteincholesterolisthemostatherogeniclipoproteinparameterintheprospectiveframinghamoffspringstudy
AT asztalosbelaf smalldenselowdensitylipoproteincholesterolisthemostatherogeniclipoproteinparameterintheprospectiveframinghamoffspringstudy
AT schaeferernstj smalldenselowdensitylipoproteincholesterolisthemostatherogeniclipoproteinparameterintheprospectiveframinghamoffspringstudy